tiprankstipranks
Neumora Therapeutics, Inc. (NMRA)
NASDAQ:NMRA
US Market
NMRA
Neumora Therapeutics, Inc.
RESEARCH TOOLSreports

Neumora Therapeutics, Inc. (NMRA) Financial Statements

397 Followers

Neumora Therapeutics, Inc. Financial Overview

Neumora Therapeutics, Inc.'s market cap is currently $364.08M. The company's EPS TTM is $-0.35; its P/E ratio is -1.23; Neumora Therapeutics, Inc. is scheduled to report earnings on March 30, 2026, and the estimated EPS forecast is $―. See an overview of income statement, balance sheet, and cash flow financials.
Dec 25Dec 24Dec 23Dec 22Dec 21
Income Statement
Total Revenue$ 0.00$ 0.00$ 0.00$ 0.00$ 0.00
Gross Profit$ -5.00M$ 0.00$ -668.00K$ 0.00$ 0.00
Operating Income$ -241.16M$ -263.46M$ -188.19M$ -135.87M$ -237.32M
EBITDA$ -241.16M$ -262.83M$ -187.53M$ -135.28M$ -236.78M
Net Income$ -236.93M$ -243.79M$ -235.93M$ -130.90M$ -237.31M
Balance Sheet
Cash & Short-Term Investments$ 182.53M$ 307.58M$ 453.98M$ 371.88M$ 409.25M
Total Assets$ 191.05M$ 316.97M$ 496.19M$ 426.23M$ 429.30M
Total Debt$ 477.00K$ 1.85M$ 5.23M$ 8.44M$ 2.05M
Net Debt$ -182.05M$ -140.29M$ -368.81M$ -232.50M$ -407.19M
Total Liabilities$ 87.18M$ 29.91M$ 27.12M$ 873.08M$ 754.52M
Stockholders' Equity$ 103.87M$ 287.06M$ 469.08M$ -446.85M$ -325.22M
Cash Flow
Free Cash Flow$ -206.44M$ -182.94M$ -163.40M$ -115.41M$ -76.24M
Operating Cash Flow$ -206.44M$ -182.94M$ -163.28M$ -114.90M$ -75.42M
Investing Cash Flow$ 168.52M$ -70.56M$ 64.39M$ -168.01M$ -817.00K
Financing Cash Flow$ 77.09M$ 21.60M$ 231.94M$ 115.74M$ 293.51M
Currency in USD

Neumora Therapeutics, Inc. Earnings and Revenue History

Income Statement >

Neumora Therapeutics, Inc. Debt to Assets

Balance Sheet >

Neumora Therapeutics, Inc. Cash Flow

Cash Flow >

Neumora Therapeutics, Inc. Forecast EPS vs Actual EPS

Earnings >